BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Forsberg F, Piccoli CW, Liu JB, Rawool NM, Merton DA, Mitchell DG, Goldberg BB. Hepatic tumor detection: MR imaging and conventional US versus pulse-inversion harmonic US of NC100100 during its reticuloendothelial system-specific phase. Radiology. 2002;222:824-829. [PMID: 11867808 DOI: 10.1148/radiol.2223001786] [Cited by in Crossref: 71] [Cited by in F6Publishing: 59] [Article Influence: 3.6] [Reference Citation Analysis]
Number Citing Articles
1 Sugimoto K, Shiraishi J, Moriyasu F, Saito K, Doi K. Improved Detection of Hepatic Metastases with Contrast-enhanced Low Mechanical-index Pulse Inversion Ultrasonography During the Liver-specific Phase of Sonazoid. Academic Radiology 2009;16:798-809. [DOI: 10.1016/j.acra.2008.12.025] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 1.8] [Reference Citation Analysis]
2 Forsberg F, Shi WT, Merritt CRB, Dai Q, Solcova M, Goldberg BB. On the Usefulness of the Mechanical Index Displayed on Clinical Ultrasound Scanners for Predicting Contrast Microbubble Destruction. Journal of Ultrasound in Medicine 2005;24:443-50. [DOI: 10.7863/jum.2005.24.4.443] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 1.5] [Reference Citation Analysis]
3 Yamamoto Y, Fujiwara Y, Yukisawa S, Matsueda K, Katori M, Yamada K, Kohno A. Three cases of angiomyolipoma: diagnostic imaging by contrast-enhanced ultrasonography. J Med Ultrason (2001) 2010;37:67-74. [PMID: 27277716 DOI: 10.1007/s10396-009-0250-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
4 Moriyasu F, Itoh K. Efficacy of perflubutane microbubble-enhanced ultrasound in the characterization and detection of focal liver lesions: phase 3 multicenter clinical trial. AJR Am J Roentgenol. 2009;193:86-95. [PMID: 19542399 DOI: 10.2214/ajr.08.1618] [Cited by in Crossref: 107] [Cited by in F6Publishing: 35] [Article Influence: 8.2] [Reference Citation Analysis]
5 Korenaga K, Korenaga M, Furukawa M, Yamasaki T, Sakaida I. Usefulness of Sonazoid contrast-enhanced ultrasonography for hepatocellular carcinoma: comparison with pathological diagnosis and superparamagnetic iron oxide magnetic resonance images. J Gastroenterol 2009;44:733-41. [PMID: 19387532 DOI: 10.1007/s00535-009-0053-7] [Cited by in Crossref: 62] [Cited by in F6Publishing: 57] [Article Influence: 4.8] [Reference Citation Analysis]
6 Hausmann D, Jochum S, Utikal J, Hoffmann RC, Zechmann C, Neff KW, Goerdt S, Schoenberg SO, Dinter DJ. Comparison of the diagnostic accuracy of whole-body MRI and whole-body CT in stage III/IV malignant melanoma. J Dtsch Dermatol Ges 2011;9:212-22. [PMID: 21352483 DOI: 10.1111/j.1610-0387.2011.07614.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
7 Kumagawa M, Matsumoto N, Watanabe Y, Hirayama M, Miura T, Nakagawara H, Ogawa M, Matsuoka S, Moriyama M, Takayama T, Sugitani M. Contrast-enhanced ultrasonographic findings of serum amyloid A-positive hepatocellular neoplasm: Does hepatocellular adenoma arise in cirrhotic liver? World J Hepatol 2016; 8(26): 1110-1115 [PMID: 27660679 DOI: 10.4254/wjh.v8.i26.1110] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
8 Emori T, Nuta J, Kawaji Y, Tamura T, Hatamaru K, Itonaga M, Yamashita Y, Ashida R, Shimokawa T, Koike M, Ikoma A, Sonomura T, Kawai M, Kitano M. Value of contrast-enhanced harmonic endoscopic ultrasound for diagnosing hepatic metastases of pancreatic cancer: A prospective study. J Gastroenterol Hepatol 2021. [PMID: 34397113 DOI: 10.1111/jgh.15661] [Reference Citation Analysis]
9 Hammerstingl R, Adam G, Ayuso J, Van Beers B, Belfiore G, Bellin M, Bongartz G, Ernst O, Frericks B, Giuseppetti G, Heinz-peer G, Laghi A, Martin J, Pering C, Reimer P, Richter G, Roemer FW, Schäfer FKW, Vilgrain V, Vogl TJ, Weishaupt D, Wall A, Zech CJ, Tombach B. Comparison of 1.0 M Gadobutrol and 0.5 M Gadopentetate Dimeglumine-Enhanced Magnetic Resonance Imaging in Five Hundred Seventy-Two Patients With Known or Suspected Liver Lesions: Results of a Multicenter, Double-Blind, Interindividual, Randomized Clinical Phase-III Trial. Investigative Radiology 2009;44:168-76. [DOI: 10.1097/rli.0b013e318198a0ae] [Cited by in Crossref: 32] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
10 Yang WY, Park HS, Kim YJ, Yu MH, Jung SI, Jeon HJ. Visibility of focal liver lesions: Comparison between kupffer phase of CEUS with sonazoid and hepatobiliary phase of gadoxetic acid-enhanced MRI. J Clin Ultrasound 2017;45:542-50. [PMID: 28547764 DOI: 10.1002/jcu.22499] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
11 Miyamoto N, Hiramatsu K, Tsuchiya K, Sato Y, Terae S, Shirato H. Sonazoid-enhanced sonography for guiding radiofrequency ablation for hepatocellular carcinoma: better tumor visualization by Kupffer-phase imaging and vascular-phase imaging after reinjection. Jpn J Radiol 2009;27:185-93. [PMID: 19499310 DOI: 10.1007/s11604-009-0317-4] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 1.8] [Reference Citation Analysis]
12 Maruyama H, Matsutani S, Saisho H, Mine Y, Kamiyama N, Hirata T, Sasamata M. Real-time blood-pool images of contrast enhanced ultrasound with Definity in the detection of tumour nodules in the liver. BJR 2005;78:512-8. [DOI: 10.1259/bjr/59648297] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
13 Nielsen MB, Bang N. Contrast enhanced ultrasound in liver imaging. Eur J Radiol 2004;51 Suppl:S3-8. [PMID: 15234020 DOI: 10.1016/j.ejrad.2004.03.022] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
14 Nakano H, Ishida Y, Hatakeyama T, Sakuraba K, Hayashi M, Sakurai O, Hataya K. Contrast-enhanced intraoperative ultrasonography equipped with late Kupffer-phase image obtained by sonazoid in patients with colorectal liver metastases. World J Gastroenterol 2008; 14(20): 3207-3211 [PMID: 18506927 DOI: 10.3748/wjg.14.3207] [Cited by in CrossRef: 55] [Cited by in F6Publishing: 47] [Article Influence: 3.9] [Reference Citation Analysis]
15 Iijima H, Moriyasu F, Tsuchiya K, Suzuki S, Yoshida M, Shimizu M, Sasaki S, Nishiguchi S, Maeyama S. Decrease in accumulation of ultrasound contrast microbubbles in non-alcoholic steatohepatitis. Hepatol Res. 2007;37:722-730. [PMID: 17559420 DOI: 10.1111/j.1872-034x.2007.00130.x] [Cited by in Crossref: 62] [Cited by in F6Publishing: 36] [Article Influence: 4.1] [Reference Citation Analysis]
16 Klibanov AL, Hossack JA. Ultrasound in Radiology: From Anatomic, Functional, Molecular Imaging to Drug Delivery and Image-Guided Therapy. Invest Radiol 2015;50:657-70. [PMID: 26200224 DOI: 10.1097/RLI.0000000000000188] [Cited by in Crossref: 35] [Cited by in F6Publishing: 14] [Article Influence: 5.8] [Reference Citation Analysis]
17 Li P, Hoppmann S, Du P, Li H, Evans PM, Moestue SA, Yu W, Dong F, Liu H, Liu L. Pharmacokinetics of Perfluorobutane after Intra-Venous Bolus Injection of Sonazoid in Healthy Chinese Volunteers. Ultrasound Med Biol 2017;43:1031-9. [PMID: 28283327 DOI: 10.1016/j.ultrasmedbio.2017.01.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
18 Uran S, Landmark K, Normann PT, Hals P, Toft KG, Skotland T. A respiration–metabolism chamber system and a GC–MS method developed for studying exhalation of perfluorobutane in rats after intravenous injection of the ultrasound contrast agent Sonazoid™. Journal of Pharmaceutical and Biomedical Analysis 2005;39:746-51. [DOI: 10.1016/j.jpba.2005.04.038] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
19 Yang WT, Tse GMK, Lam PKW, Metreweli C, Chang J. Correlation Between Color Power Doppler Sonographic Measurement of Breast Tumor Vasculature and Immunohistochemical Analysis of Microvessel Density for the Quantitation of Angiogenesis. Journal of Ultrasound in Medicine 2002;21:1227-35. [DOI: 10.7863/jum.2002.21.11.1227] [Cited by in Crossref: 75] [Cited by in F6Publishing: 62] [Article Influence: 3.8] [Reference Citation Analysis]
20 Halavaara J, Breuer J, Ayuso C, Balzer T, Bellin MF, Blomqvist L, Carter R, Grazioli L, Hammerstingl R, Huppertz A. Liver tumor characterization: comparison between liver-specific gadoxetic acid disodium-enhanced MRI and biphasic CT--a multicenter trial. J Comput Assist Tomogr. 2006;30:345-354. [PMID: 16778605 DOI: 10.1097/00004728-200605000-00001] [Cited by in Crossref: 142] [Cited by in F6Publishing: 125] [Article Influence: 8.9] [Reference Citation Analysis]
21 Toft KG, Hustvedt SO, Hals PA, Oulie I, Uran S, Landmark K, Normann PT, Skotland T. Disposition of perfluorobutane in rats after intravenous injection of Sonazoid. Ultrasound Med Biol. 2006;32:107-114. [PMID: 16364802 DOI: 10.1016/j.ultrasmedbio.2005.09.008] [Cited by in Crossref: 43] [Cited by in F6Publishing: 40] [Article Influence: 2.7] [Reference Citation Analysis]
22 Sugimoto K, Moriyasu F, Saito K, Taira J, Saguchi T, Yoshimura N, Oshiro H, Imai Y, Shiraishi J. Comparison of Kupffer-phase Sonazoid-enhanced sonography and hepatobiliary-phase gadoxetic acid-enhanced magnetic resonance imaging of hepatocellular carcinoma and correlation with histologic grading. J Ultrasound Med 2012;31:529-38. [PMID: 22441909 DOI: 10.7863/jum.2012.31.4.529] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 2.4] [Reference Citation Analysis]
23 Miller JC, Thrall JH. Clinical molecular imaging. Journal of the American College of Radiology 2004;1:4-23. [DOI: 10.1016/s1546-1440(03)00025-5] [Cited by in Crossref: 44] [Cited by in F6Publishing: 9] [Article Influence: 2.4] [Reference Citation Analysis]
24 Wakui N, Nagai H, Yoshimine N, Amanuma M, Kobayashi K, Ogino Y, Matsui D, Mukozu T, Matsukiyo Y, Matsui T, Daido Y, Momiyama K, Shinohara M, Kudo T, Maruyama K, Sumino Y, Igarashi Y. Flash Imaging Used in the Post-vascular Phase of Contrast-Enhanced Ultrasonography is Useful for Assessing the Progression in Patients with Hepatitis C Virus-Related Liver Disease. Ultrasound Med Biol. 2019;45:1654-1662. [PMID: 31031037 DOI: 10.1016/j.ultrasmedbio.2019.03.005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
25 Mishima M, Toh U, Iwakuma N, Takenaka M, Furukawa M, Akagi Y. Evaluation of contrast Sonazoid-enhanced ultrasonography for the detection of hepatic metastases in breast cancer. Breast Cancer 2016;23:231-41. [PMID: 25143060 DOI: 10.1007/s12282-014-0560-0] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
26 Forsberg F, Shi WT, Knauer MK, Hall AL, Vecchio C, Bernardi R. Real-time excitation-enhanced ultrasound contrast imaging. Ultrason Imaging 2005;27:65-74. [PMID: 16231836 DOI: 10.1177/016173460502700201] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
27 Mitsunori Y, Tanaka S, Nakamura N, Ban D, Irie T, Noguchi N, Kudo A, Iijima H, Arii S. Contrast-enhanced intraoperative ultrasound for hepatocellular carcinoma: high sensitivity of diagnosis and therapeutic impact. J Hepatobiliary Pancreat Sci 2013;20:234-42. [PMID: 22399158 DOI: 10.1007/s00534-012-0507-9] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
28 Li K, Thomasson D, Ketai L, Contag C, Pomper M, Wright M, Bray M. Potential applications of conventional and molecular imaging to biodefense research. Clin Infect Dis 2005;40:1471-80. [PMID: 15844070 DOI: 10.1086/429723] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
29 Iijima H, Sasaki S, Moriyasu F, Suzuki S, Yoshida M, Horibe T, Tsuchiya K. Dynamic US contrast study of the liver: Vascular and delayed parenchymal phase. Hepatol Res 2007;37:27-34. [PMID: 17300696 DOI: 10.1111/j.1872-034X.2007.00001.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
30 Numata K, Luo W, Morimoto M, Kondo M, Kunishi Y, Sasaki T, Nozaki A, Tanaka K. Contrast enhanced ultrasound of hepatocellular carcinoma. World J Radiol 2010; 2(2): 68-82 [PMID: 21160920 DOI: 10.4329/wjr.v2.i2.68] [Cited by in CrossRef: 45] [Cited by in F6Publishing: 33] [Article Influence: 3.8] [Reference Citation Analysis]
31 Gummadi S, Eisenbrey JR, Lyshchik A. Contrast-enhanced ultrasonography in interventional oncology. Abdom Radiol (NY) 2018;43:3166-75. [PMID: 29632993 DOI: 10.1007/s00261-018-1581-5] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
32 Suzuki K, Okuda Y, Ota M, Kojima F, Horimoto M. Diagnosis of Hepatocellular Carcinoma Nodules in Patients With Chronic Liver Disease Using Contrast-Enhanced Sonography: Usefulness of the Combination of Arterial- and Kupffer-Phase Enhancement Patterns. Journal of Ultrasound in Medicine 2015;34:423-33. [DOI: 10.7863/ultra.34.3.423] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
33 Park HS, Kim YJ, Yu MH, Jung SI, Jeon HJ. Real-time Contrast-Enhanced Sonographically Guided Biopsy or Radiofrequency Ablation of Focal Liver Lesions Using Perflurobutane Microbubbles (Sonazoid): Value of Kupffer-Phase Imaging. Journal of Ultrasound in Medicine 2015;34:411-21. [DOI: 10.7863/ultra.34.3.411] [Cited by in Crossref: 20] [Cited by in F6Publishing: 24] [Article Influence: 2.9] [Reference Citation Analysis]
34 Wu H, Rognin NG, Krupka TM, Solorio L, Yoshiara H, Guenette G, Sanders C, Kamiyama N, Exner AA. Acoustic characterization and pharmacokinetic analyses of new nanobubble ultrasound contrast agents. Ultrasound Med Biol. 2013;39:2137-2146. [PMID: 23932272 DOI: 10.1016/j.ultrasmedbio.2013.05.007] [Cited by in Crossref: 83] [Cited by in F6Publishing: 70] [Article Influence: 9.2] [Reference Citation Analysis]
35 Sasaki H, Yamauchi M, Ninomiya T, Tatsumi H, Yamakage M. Possible utility of contrast-enhanced ultrasonography for detecting spread of local anesthetic in nerve block. J Anesth 2017;31:365-73. [DOI: 10.1007/s00540-017-2347-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
36 Joshita S, Ichijo T, Suzuki F, Yokoyama T, Sugiyama Y, Fukushima M, Kamijo A, Komatsu M, Umemura T, Yoshizawa K, Miyagawa S, Tanaka E. A case of well-differentiated cholangiolocellular carcinoma visualized with contrast-enhanced ultrasonography using Sonazoid. Hepatology Research 2009;39:207-12. [DOI: 10.1111/j.1872-034x.2008.00446.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
37 Shiozawa K, Watanabe M, Takayama R, Takahashi M, Wakui N, Iida K, Sumino Y. Evaluation of local recurrence after treatment for hepatocellular carcinoma by contrast-enhanced ultrasonography using Sonazoid: comparison with dynamic computed tomography. J Clin Ultrasound 2010;38:182-9. [PMID: 20232404 DOI: 10.1002/jcu.20685] [Cited by in Crossref: 2] [Cited by in F6Publishing: 9] [Article Influence: 0.2] [Reference Citation Analysis]
38 Furuse J, Nagase M, Ishii H, Yoshino M. Contrast enhancement patterns of hepatic tumours during the vascular phase using coded harmonic imaging and Levovist to differentiate hepatocellular carcinoma from other focal lesions. Br J Radiol 2003;76:385-92. [PMID: 12814924 DOI: 10.1259/bjr/14206699] [Cited by in Crossref: 42] [Cited by in F6Publishing: 31] [Article Influence: 2.2] [Reference Citation Analysis]
39 Quaia E. Classification and Safety of Microbubble-Based Contrast Agents. In: Quaia E, editor. Contrast Media in Ultrasonography. Berlin/Heidelberg: Springer-Verlag; 2005. pp. 3-14. [DOI: 10.1007/3-540-27214-3_1] [Cited by in Crossref: 13] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
40 Shunichi S, Hiroko I, Fuminori M, Waki H. Definition of Contrast Enhancement Phases of the Liver Using a Perfluoro-Based Microbubble Agent, Perflubutane Microbubbles. Ultrasound in Medicine & Biology 2009;35:1819-27. [DOI: 10.1016/j.ultrasmedbio.2009.05.013] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 2.4] [Reference Citation Analysis]
41 Luo BM, Wen YL, Yang HY, Zhi H, Ou B, Ma JH, Pan JS, Dai XN. Differentiation between malignant and benign nodules in the liver: Use of contrast C3-MODE technology. World J Gastroenterol 2005; 11(16): 2402-2407 [PMID: 15832408 DOI: 10.3748/wjg.v11.i16.2402] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
42 Watanabe R, Matsumura M, Munemasa T, Fujimaki M, Suematsu M. Mechanism of hepatic parenchyma-specific contrast of microbubble-based contrast agent for ultrasonography: microscopic studies in rat liver. Invest Radiol. 2007;42:643-651. [PMID: 17700280 DOI: 10.1097/rli.0b013e31805f2682] [Cited by in Crossref: 79] [Cited by in F6Publishing: 28] [Article Influence: 5.3] [Reference Citation Analysis]
43 Maruyama H, Ebara M. Recent applications of ultrasound: diagnosis and treatment of hepatocellular carcinoma. Int J Clin Oncol 2006;11:258-67. [PMID: 16937299 DOI: 10.1007/s10147-006-0585-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
44 Haers H, Smets P, Pey P, Piron K, Daminet S, Saunders JH. CONTRAST HARMONIC ULTRASOUND APPEARANCE OF CONSECUTIVE PERCUTANEOUS RENAL BIOPSIES IN DOGS: Contrast Ultrasound Appearance of Renal Biopsies. Veterinary Radiology & Ultrasound 2011;52:640-7. [DOI: 10.1111/j.1740-8261.2011.01843.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
45 Numata K, Morimoto M, Ogura T, Sugimori K, Takebayashi S, Okada M, Tanaka K. Ablation therapy guided by contrast-enhanced sonography with Sonazoid for hepatocellular carcinoma lesions not detected by conventional sonography. J Ultrasound Med 2008;27:395-406. [PMID: 18314518 DOI: 10.7863/jum.2008.27.3.395] [Cited by in Crossref: 69] [Cited by in F6Publishing: 55] [Article Influence: 4.9] [Reference Citation Analysis]
46 Kamiyama T, Kakisaka T, Orimo T. Current role of intraoperative ultrasonography in hepatectomy. Surg Today 2021. [PMID: 33394137 DOI: 10.1007/s00595-020-02219-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
47 Kondo T, Maruyama H, Sekimoto T, Shimada T, Takahashi M, Chiba T, Kanai F, Yokosuka O, Yamaguchi T. Natural history of postvascular-phase iso-enhanced lesions on the sonogram in chronic liver diseases. J Gastroenterol Hepatol 2014;29:165-72. [PMID: 24224484 DOI: 10.1111/jgh.12449] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
48 Landmark KE, Johansen PW, Johnson JA, Johansen B, Uran S, Skotland T. Pharmacokinetics of perfluorobutane following intravenous bolus injection and continuous infusion of sonazoid in healthy volunteers and in patients with reduced pulmonary diffusing capacity. Ultrasound Med Biol 2008;34:494-501. [PMID: 18096304 DOI: 10.1016/j.ultrasmedbio.2007.09.019] [Cited by in Crossref: 47] [Cited by in F6Publishing: 41] [Article Influence: 3.1] [Reference Citation Analysis]
49 Zhai HY, Liang P, Yu J, Cao F, Kuang M, Liu FY, Zhu XY. Comparison of sonazoid and sonoVue in the diagnosis of focal liver lesions: A preliminary study. J Ultrasound Med. 2019;38:2417-2425. [PMID: 30680779 DOI: 10.1002/jum.14940] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
50 Liu W, Zhang ZY, Yin SS, Yan K, Xing BC. Contrast-Enhanced Intraoperative Ultrasound Improved Sensitivity and Positive Predictive Value in Colorectal Liver Metastasis: a Systematic Review and Meta-Analysis. Ann Surg Oncol 2021;28:3763-73. [PMID: 33247361 DOI: 10.1245/s10434-020-09365-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
51 Klibanov AL. Ultrasound Molecular Imaging of Cancer: Design and Formulation Strategies of Targeted Contrast Agents. In: Schober O, Kiessling F, Debus J, editors. Molecular Imaging in Oncology. Cham: Springer International Publishing; 2020. pp. 319-36. [DOI: 10.1007/978-3-030-42618-7_9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
52 Lee JM, Youk JH, Lee YH, Kim YK, Kim CS, Li CA. Detection of hepatic VX2 tumors in rabbits: comparison of conventional US and phase-inversion harmonic US during the liver-specific late phase of contrast enhancement. Korean J Radiol 2003;4:124-9. [PMID: 12845308 DOI: 10.3348/kjr.2003.4.2.124] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
53 Liu GJ, Moriyasu F, Hirokawa T, Rexiati M, Yamada M, Imai Y. Optical microscopic findings of the behavior of perflubutane microbubbles outside and inside Kupffer cells during diagnostic ultrasound examination. Invest Radiol 2008;43:829-36. [PMID: 19002054 DOI: 10.1097/RLI.0b013e3181852719] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
54 Edey A, Ryan S, Beese R, Gordon P, Sidhu P. Ultrasound imaging of liver metastases in the delayed parenchymal phase following administration of Sonazoid™ using a destructive mode technique (Agent Detection Imaging™). Clinical Radiology 2008;63:1112-20. [DOI: 10.1016/j.crad.2008.03.008] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
55 Goldberg BB, Merton DA, Liu JB, Thakur M, Murphy GF, Needleman L, Tornes A, Forsberg F. Sentinel lymph nodes in a swine model with melanoma: contrast-enhanced lymphatic US. Radiology 2004;230:727-34. [PMID: 14990839 DOI: 10.1148/radiol.2303021440] [Cited by in Crossref: 113] [Cited by in F6Publishing: 97] [Article Influence: 6.3] [Reference Citation Analysis]
56 Yuan YH, Xiao EH, He Z, Xiang J, Tang KL, Yan RH, Jin K, Peng ZW. MR diffusion-weighed imaging of rabbit liver. World J Gastroenterol 2005; 11(35): 5506-5511 [PMID: 16222744 DOI: 10.3748/wjg.v11.i35.5506] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
57 Maruyama H, Matsutani S, Okugawa H, Kobayashi S, Yoshizumi H, Ebara M, Saisho H. Microbubble disappearance-time is the appropriate timing for liver-specific imaging after injection of Levovist. Ultrasound in Medicine & Biology 2006;32:1809-15. [DOI: 10.1016/j.ultrasmedbio.2006.06.024] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
58 Maruyama H, Matsutani S, Kondo F, Yoshizumi H, Kobayashi S, Okugawa H, Ebara M, Saisho H. Ring-shaped appearance in liver-specific image with Levovist: a characteristic enhancement pattern for hypervascular benign nodule in the liver of heavy drinkers. Liver Int 2006;26:688-94. [PMID: 16842325 DOI: 10.1111/j.1478-3231.2006.01286.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
59 Szatmari V, Harkaanyi Z, Voaroas K. A REVIEW OF NONCONVENTIONAL ULTRASOUND TECHNIQUES AND CONTRAST-ENHANCED ULTRASONOGRAPHY OF NONCARDIAC CANINE DISORDERS. Veterinary Radiology & Ultrasound 2003;44:380-91. [DOI: 10.1111/j.1740-8261.2003.tb00474.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]